Remi A Nout

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. ncbi Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation
    Remi A Nout
    Department of Clinical Oncology, Leiden University Medical Center, The Netherlands
    Gynecol Oncol 126:466-73. 2012
  2. ncbi Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data
    Remi A Nout
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Eur J Cancer 48:1638-48. 2012
  3. ncbi The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
    R A Nout
    Department of Clinical Oncology, Leiden University Medical Center, P O Box 9600, 2300 RC, Leiden, The Netherlands
    Breast Cancer Res Treat 109:567-72. 2008
  4. ncbi Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial
    Remi A Nout
    Department of Clinical Oncology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    J Clin Oncol 27:3547-56. 2009
  5. ncbi Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
    R A Nout
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands
    Lancet 375:816-23. 2010
  6. ncbi Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial
    Remi A Nout
    Department of Clinical Oncology, Leiden University Medical Center, PO PO Box 9600, 2300 RC Leiden, The Netherlands
    J Clin Oncol 29:1692-700. 2011
  7. ncbi Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma
    Carien L Creutzberg
    Department of Clinical Oncology, Leiden University Medical Center, The Netherlands
    Int J Radiat Oncol Biol Phys 81:e631-8. 2011
  8. ncbi The role of radiotherapy in endometrial cancer: current evidence and trends
    Carien L Creutzberg
    Department of Clinical Oncology, Leiden University Medical Center, The Netherlands
    Curr Oncol Rep 13:472-8. 2011
  9. ncbi Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy
    Joeke M Felderhof
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Acta Oncol 52:745-52. 2013

Detail Information

Publications9

  1. ncbi Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation
    Remi A Nout
    Department of Clinical Oncology, Leiden University Medical Center, The Netherlands
    Gynecol Oncol 126:466-73. 2012
    ....
  2. ncbi Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data
    Remi A Nout
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Eur J Cancer 48:1638-48. 2012
    ..The current analysis was done to evaluate long-term health related quality of life (HRQL), and compare HRQL of patients to an age-matched norm population...
  3. ncbi The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
    R A Nout
    Department of Clinical Oncology, Leiden University Medical Center, P O Box 9600, 2300 RC, Leiden, The Netherlands
    Breast Cancer Res Treat 109:567-72. 2008
    ..Knowledge of the contribution of non-disease related death or contralateral breast cancer to estimated recurrent disease rate and overall death rate is indispensable for a correct interpretation and comparison of outcome analyses...
  4. ncbi Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial
    Remi A Nout
    Department of Clinical Oncology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    J Clin Oncol 27:3547-56. 2009
    ..Vaginal brachytherapy provides a better QOL, and should be the preferred treatment from a QOL perspective...
  5. ncbi Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
    R A Nout
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands
    Lancet 375:816-23. 2010
    ..This study established whether vaginal brachytherapy (VBT) is as effective as pelvic external beam radiotherapy (EBRT) in prevention of vaginal recurrence, with fewer adverse effects and improved quality of life...
  6. ncbi Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial
    Remi A Nout
    Department of Clinical Oncology, Leiden University Medical Center, PO PO Box 9600, 2300 RC Leiden, The Netherlands
    J Clin Oncol 29:1692-700. 2011
    ....
  7. ncbi Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma
    Carien L Creutzberg
    Department of Clinical Oncology, Leiden University Medical Center, The Netherlands
    Int J Radiat Oncol Biol Phys 81:e631-8. 2011
    ....
  8. ncbi The role of radiotherapy in endometrial cancer: current evidence and trends
    Carien L Creutzberg
    Department of Clinical Oncology, Leiden University Medical Center, The Netherlands
    Curr Oncol Rep 13:472-8. 2011
    ..Current ongoing trials are exploring the role of combined RT and chemotherapy, compared to chemotherapy or RT alone...
  9. ncbi Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy
    Joeke M Felderhof
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Acta Oncol 52:745-52. 2013
    ..5% severe limitations. Conclusion. Limb-sparing surgery with 60 Gy postoperative radiotherapy for patients with STS provides excellent local control and high survival rates with acceptable toxicity and functional outcomes...